Since each of DNMT3A, FLT3‐ITD, and NPM1 genes predicted relatively higher incidences of mutation compared to other genes in the total cohort and significantly co‐occurred with each other, we explored their comprehensive prognostic meanings in AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.